Corbin Capital Partners »

Soleno Therapeutics shares owned by Corbin Capital Partners

Quarter-by-quarter ownership of Soleno Therapeutics (SLNO) shares owned by Corbin Capital Partners from 13F filings

Historical chart of Corbin Capital Partners investment in Soleno Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Soleno Therapeutics held by Corbin Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Soleno Therapeutics by Corbin Capital Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $590k 12k 50.49

More positions owned by Corbin Capital Partners

Endeavor Group Hldgs Cl A Com (EDR)
Core Scientific Call Option (CORZ)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)
Arbutus Biopharma (ABUS)
Evolv Technologies Hldngs In Com Cl A (EVLV)
Roivant Sciences SHS (ROIV)
Seritage Growth Pptys Cl A (SRG)
Soleno Therapeutics (SLNO)
Hippo Hldgs Com New (HIPO)
Alpha Tau Medical *w Exp 99/99/999 (DRTSW)
Hertz Global Hldgs Com New (HTZ)
Archer Aviation *w Exp 09/16/202 (ACHR.WS)
Terran Orbital Corporation (LLAP)
Niocorp Devs *w Exp 03/17/202 (NIOBW)

View all positions for Corbin Capital Partners

Top funds holding Soleno Therapeutics

Carlyle
Henderson Group
Nantahala Capital Management
Perceptive Advisors
BlackRock
BlackRock
Vanguard Group
T. Rowe Price Associates
Commodore Capital
State Street Corporation
Alyeska Investment Group
Sofinnova Ventures
Frazier Life Sciences Management
Vestal Point Capital
Holocene Advisors

View all funds holding Soleno Therapeutics